LIFE EXPECTANCY DISPARITIES AMONG ADULTS WITH HIV IN THE UNITED STATES AND CANADA: THE IMPACT OF A REDUCTION IN DRUG- AND ALCOHOL-RELATED DEATHS USING THE LIVES SAVED SIMULATION (LISSO) MODEL.
Improvements in life expectancy among people with HIV (PWH) receiving antiretroviral treatment in the United States and Canada may differ among key populations. Given the difference in substance use among key populations and the current opioid epidemic, drug- and alcohol-related deaths maybe contributing to the disparities in life expectancy. We sought to estimate in life expectancy at age 20 in key populations (and their comparison groups) in three time periods (2004-7, 2008-11, 2012-15), and the potential increase in expected life expectancy with a simulated 20% reduction in drug- and alcoholrelated deaths using the novel Lives Saved Simulation model. Among 92,289 PWH, life expectancy increased in all key populations and comparison groups from 2004-7 to 2012-15. Disparities in survival of approximately a decade persisted among Black vs. White men who have sex with men and people with (vs. without) a history of injection drug use. A 20% reduction in drug- and alcohol-related mortality would have the greatest life expectancy benefit for Black men who have sex with men, White women, and people with a history of injection drug use. Our findings suggest that preventing drug- and alcoholrelated deaths among PWH could narrow disparities in life expectancy among some key populations, but other causes of death must be addressed to further narrow the disparities.